Publications by authors named "Rodney R Walters"

Claim this Profile
A
A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody.
Gina M Michels, Nicole A Honsberger, Rodney R Walters, Jezaniah Kira S Tena, Dawn M Cleaver

Vet Anaesth Analg· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory safety evaluation of lokivetmab, a canine anti-interleukin-31 monoclonal antibody, in dogs.
Matthew Krautmann, Rodney R Walters, Vickie L King, Kevin Esch, Sean P Mahabir

Vet Immunol Immunopathol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onset and duration of action of lokivetmab in a canine model of IL-31 induced pruritus.
Timothy J Fleck, Lori R Norris, Sean Mahabir, Rodney R Walters, Olivier Martinon

Vet Dermatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis.
Maria J Corral, Hilde Moyaert, Tiago Fernandes, Monica Escalada, Jezaniah Kira S Tena, Rodney R Walters

Vet Anaesth Analg· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Immunogenicity of Frunevetmab in Osteoarthritic Cats Following Intravenous and Subcutaneous Administration.
Rodney R Walters, Joseph F Boucher, Flavia De Toni

Front Vet Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.
Hilde Moyaert, Leen Van Brussel, Stasia Borowski, Monica Escalada, Sean P Mahabir, Rodney R Walters

Vet Dermatol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.
Gina M Michels, Kelly F Walsh, Kristina A Kryda, Sean P Mahabir, Rodney R Walters

Vet Dermatol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
Gina M Michels, Deborah S Ramsey, Kelly F Walsh, Olivier M Martinon, Sean P Mahabir, Rodney R Walters

Vet Dermatol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current cytochrome P450 phenotyping methods applied to metabolic drug-drug interaction prediction in dogs.
Beth Miskimins Mills, Matthew J Zaya, Rodney R Walters, Kenneth L Feenstra, Julie A White

Drug Metab Dispos· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity.
Brad A Acker, E Jon Jacobsen, Bruce N Rogers, Donn G Wishka, Steven C Reitz, Rodney R Walters

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists.
Daniel P Walker, Donn G Wishka, David W Piotrowski, Shaojuan Jia, Steven C Reitz, Rodney R Walters

Bioorg Med Chem· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.
Donn G Wishka, Daniel P Walker, Karen M Yates, Steven C Reitz, Shaojuan Jia, Rodney R Walters

J Med Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis